Ossianix's Convertible Note Round

Ossianix raised a round of funding on January 03, 2012. Investors include H. Lundbeck.

Ossianix develops biopharmaceuticals for a variety of therapeutic areas. The company utilizes the single domain shark vNAR scaffold to engineer differentiated products in a variety of formats.…

Articles about Ossianix's Convertible Note Round: